Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of LanzaTech Global, Inc. (NASDAQ: LNZA) Shareholders Who Held AMCI Acquisition Corp. II (“AMCI”) Shares Prior to the Merger
NEWTOWN, PA, March 20, 2023 — The law firm of Edelson Lechtzin LLP is investigating securities fraud and breach of fiduciary duty claims on behalf of shareholders of AMCI Acquisition Corp. II (“AMCI”) (NASDAQ: AMCI and AMCIW), a special purpose acquisition company (“SPAC”), who acquired AMCI shares before the closing of its business combination with LanzaTech Global, Inc. (“LanzaTech”) (NASDAQ: LNZA), on or before February 6, 2023.
LanzaTech is an innovative carbon capture and transformation company that converts waste carbon into materials such as sustainable fuels, fabrics, packaging and other products that people use in their daily lives. LanzaTech maintains its principal executive offices in Skokie, Illinois. The business combination of AMCI and LanzaTech was approved by AMCI shareholders at its Special Meeting held on February 6, 2023. LanzaTech common stock began trading on the NASDAQ under its new ticker symbol “LNZA”, on February 10, 2023.
AMCI investors may have claims based on alleged false and misleading statements and/or material omissions contained in the documents used to solicit shareholder approval for the business combination between AMCI and LanzaTech. Please contact Edelson Lechtzin LLP at 844-696-7492 to discuss your investment losses, or by e-mail at [email protected] or [email protected].
For more information, please contact:
Marc H. Edelson, Esq.
Eric Lechtzin, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Email: [email protected] or [email protected]
Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving securities and investment fraud, our lawyers focus on class and collective litigation in cases alleging violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and dangerous and defective drugs and medical devices.
This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. Your ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.